Your browser doesn't support javascript.
loading
Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases.
Li, Hongwei; Lian, Jianhong; Han, Songyan; Wang, Weili; Jia, Haixia; Cao, Jianzhong; Zhang, Xiaqin; Song, Xin; Jia, Sufang; Ren, Jiwei; Yang, Weihua; Xi, Yanfeng; Lan, Shengmin.
Afiliação
  • Li H; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Lian J; Department of Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Han S; Department of Chemotherapy, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Wang W; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Jia H; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Cao J; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Zhang X; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Song X; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Jia S; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Ren J; Department of Medical Imageology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Yang W; Department of Chemotherapy, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Xi Y; Department of Pathology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
  • Lan S; Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province 030013, People's Republic of China.
Oncotarget ; 8(41): 70727-70735, 2017 Sep 19.
Article em En | MEDLINE | ID: mdl-29050314

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article